These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 790125)
1. [Evidence for the action of raubasine from a new formulation of Lamuran tablets]. Glocke M; Grübl M; Klein K; Teufel W Med Klin; 1976 Sep; 71(38):1564-8. PubMed ID: 790125 [TBL] [Abstract][Full Text] [Related]
2. [Modification of cerebrovascular diseases through the oral administration of raubasine]. Klein K; Grübl M Wien Med Wochenschr; 1974 Jun; 124(23):360-4. PubMed ID: 4599577 [No Abstract] [Full Text] [Related]
3. [Action of raubasine (new formulation) in arterial occlusive diseases (author's transl)]. Schütz RM; Teufel W; Glocke M Med Klin; 1976 Sep; 71(39):1605-10. PubMed ID: 790128 [TBL] [Abstract][Full Text] [Related]
4. [The cerebral blood-flow-volume in patients with sclerotic changes after treatment with raubasin (Lamuran)]. Klemm J; Scheuring HJ Med Klin; 1974 May; 69(21):947-52. PubMed ID: 4602944 [No Abstract] [Full Text] [Related]
5. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years. Kisicki JC; Fiske K; Lyne A Clin Ther; 2007 Sep; 29(9):1967-79. PubMed ID: 18035196 [TBL] [Abstract][Full Text] [Related]
6. [Psychometric evaluation of the effects of an almitrine-raubasine combination in the intellectual deterioration of aged subjects. A double-blind controlled trial versus placebo]. Rapisarda V; Azzaro E; Fichera G Presse Med; 1987 Jun; 16(23):1163-6. PubMed ID: 2885827 [TBL] [Abstract][Full Text] [Related]
7. Carotid endarterectomy improves cerebrovascular reserve capacity preferentially in patients with preoperative impairment as indicated by asymmetric BOLD response to hypercapnia. Goode SD; Altaf N; Auer DP; MacSweeney ST Eur J Vasc Endovasc Surg; 2009 Nov; 38(5):546-51. PubMed ID: 19744868 [TBL] [Abstract][Full Text] [Related]
8. Quantitative electroencephalography in aging brain and cerebrovascular disease: the effects of almitrine-raubasine. Sebban C Eur Neurol; 1995; 35 Suppl 1():37-42. PubMed ID: 8529728 [No Abstract] [Full Text] [Related]
9. Yohimbine and the model anxiety state. Henauer SA; Gillespie HK; Hollister LE J Clin Psychiatry; 1984 Dec; 45(12):512-5. PubMed ID: 6501237 [TBL] [Abstract][Full Text] [Related]
10. [Antinoradrenergic activity of raubasine on isolated thoracic aorta and vas deferens of rat (author's transl)]. Roquebert J; Gomond P; Demichel P J Pharmacol; 1981; 12(4):393-403. PubMed ID: 6119400 [TBL] [Abstract][Full Text] [Related]
11. Assessment of the therapeutic activity of a combination of almitrine and raubasine on functional rehabilitation following ischaemic stroke. Li S; Long J; Ma Z; Xu Z; Li J; Zhang Z Curr Med Res Opin; 2004 Mar; 20(3):409-15. PubMed ID: 15025850 [TBL] [Abstract][Full Text] [Related]
12. Clinical evaluation of GABA in the treatment of cerebrovascular disorders. Multi-center double-blind study in comparison with pyrithioxine and placebo. Otomo E; Araki G; Mori A; Kurihara M Arzneimittelforschung; 1981; 31(9):1511-23. PubMed ID: 7030354 [TBL] [Abstract][Full Text] [Related]
13. [Treatment of cerebrovascular deficiencies. Therapeutic evaluation from 129 cases using the double-blind method against placebo]. Bargheon J; Durocher AM; Lagrange M Sem Hop; 1984 Jan; 60(3):169-74. PubMed ID: 6320441 [TBL] [Abstract][Full Text] [Related]
14. Beneficial effect of papaverine plus raubasine in peripheral arterial insufficiency. Brevetti G; Chiariello M; Verrienti S; Spena M; Desiderati M; Condorelli M Angiology; 1983 Aug; 34(8):517-26. PubMed ID: 6614583 [TBL] [Abstract][Full Text] [Related]
15. Quantitative study of the effects of Ketanserin in patients with primary Raynaud's phenomenon. A randomized, double blind, placebo controlled investigation and an additional long term open trial. van de Wal HJ; Wijn PF; van Lier HJ; Skotnicki SH Microcirc Endothelium Lymphatics; 1985; 2(6):657-85. PubMed ID: 2942753 [TBL] [Abstract][Full Text] [Related]
16. Curative effect of an almitrine-raubasine combination in the postischemic syndrome following transient cerebral ischemia in dogs. Cahn R; Cahn J Pharmacology; 1988; 36(3):156-65. PubMed ID: 3368502 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of almitrine-raubasine in cognitive disorders of aging: a double-blind, placebo-controlled, clinical and psychometric study. Carbonin PU; Greco A; Pisanti P; Gemma A; Cattelin F Clin Neuropharmacol; 1990; 13 Suppl 3():S92-9. PubMed ID: 2093422 [TBL] [Abstract][Full Text] [Related]
18. [Differential inhibition of raubasine and tetrahydroalstonine on the vasopressor response to sympathetic nervous stimulation and intravenous noradrenaline in the pithed rat]. Roquebert J; Demichel P; Dufour P J Pharmacol; 1985; 16(4):412-20. PubMed ID: 2869187 [TBL] [Abstract][Full Text] [Related]
19. [Treatment of cerebral circulatory insufficiency. Double-blind study of the efficacy of a quinine-papaverine combination]. Klemm J Fortschr Med; 1984 Oct; 102(39):1000-2. PubMed ID: 6389288 [TBL] [Abstract][Full Text] [Related]
20. Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion. Alvarez XA; Mouzo R; Pichel V; Pérez P; Laredo M; Fernández-Novoa L; Corzo L; Zas R; Alcaraz M; Secades JJ; Lozano R; Cacabelos R Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):633-44. PubMed ID: 10669911 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]